Enhanced Safety Surveillance of Influenza Vaccines in General Practice, Winter 2015-16: Feasibility Study

BACKGROUND: The European Medicines Agency (EMA) requires vaccine manufacturers to conduct enhanced real-time surveillance of seasonal influenza vaccination. The EMA has specified a list of adverse events of interest to be monitored. The EMA sets out 3 different ways to conduct such surveillance: (1)...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:JMIR Public Health Surveill
Autori principali: de Lusignan, Simon, Correa, Ana, Dos Santos, Gaël, Meyer, Nadia, Haguinet, François, Webb, Rebecca, McGee, Christopher, Byford, Rachel, Yonova, Ivelina, Pathirannehelage, Sameera, Ferreira, Filipa Matos, Jones, Simon
Natura: Artigo
Lingua:Inglês
Pubblicazione: JMIR Publications 2019
Soggetti:
Original Paper
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6913774/
https://ncbi.nlm.nih.gov/pubmed/31724955
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2196/12016
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi